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Value of PCR as a de-escalation tool for an Antimicrobial Stewardship Program                
at a community-based hospital
Wilbert J. Fuerte, Pharm.D., BCIDP, Jorge Mejia, MD, Winifred Pardo, Pharm.D., BCPS, Patricia Yulkowski BSN, Silvia Costales BSMT
Homestead Hospital, Homestead, Florida
Background
 On January 29th, 2016, the facility acquired the 
FilmArray Respiratory Panel (BioFire) TM 
Diagnostics, Inc, the first multiplex polymerase 
chain reaction (PCR) molecular panel approved by 
the FDA for the detection of both bacterial and viral 
respiratory pathogens.
 Sensitivity and specificity of this technology has 
been reported as 80-100%, and 100%, 
respectively1, allowing for an optimal approach in 
the diagnosis of influenza and other organisms.
 An essential element of an Antimicrobial 
Stewardship Program (ASP) as outlined by the 
CDC and Joint Commission is to perform a 
“48-hour timeout” to assess the patient for 
opportunities, including de-escalation and 
discontinuation of antimicrobials2.
 At our facility, we identified the need to review 
patients prescribed oseltamivir and any associated 
antibiotics for ASP opportunities.  With the PCR 
tool available pharmacists were educated through 
an associated workflow to contact prescribers 
(within 48 hours) for de-escalation of oseltamivir 
when results were negative for influenza. For 
influenza positive patients who were also 
prescribed antibiotics, a procalcitonin level was 
recommended, and if appropriate, antibiotic de-
escalation was suggested.  Additionally, 
pharmacists notified nursing to initiate or 
discontinue droplet isolation based on the PCR 
influenza results.
Methods
 This study was determined to be exempt by Baptist 
Health South Florida Institutional Review Board.
 Single-center, retrospective chart review. 
 Study period: October 1st, 2017 through March 
31st, 2018.
 Inclusion Criteria: 
 Patients 18 years of age and older.
 Receiving oseltamivir with an associated 
pharmacist intervention documented.
 Exclusion Criteria: 
 Patients younger than 18 years of age
 Receiving oseltamivir with no associated 
documented intervention.
 List generated for patients receiving oseltamivir 
with an associated ASP intervention documented 
was obtained from a data analytics platform. 
 Charts were reviewed for PCR results, pharmacist 
intervention data, procalcitonin levels, and 30-day 
readmission rate. 
 Group purchasing organization (GPO) pricing of 
antimicrobials was utilized for estimated cost-
savings. 
 Pharmacist Workflow:
Results Limitations 
References
 Only patients for whom an ASP intervention was 
documented were included in this project. 
 Patients with negative PCR and associated 
antibiotics were not reviewed. 
 30-day readmission was only assessed within the 
Baptist Health South Florida (BHSF) system. 
Objectives
1. To evaluate the effectiveness of pharmacist 
interventions utilizing PCR results for patients 
receiving oseltamivir and concurrent antibiotics
2. To determine intervention results by pharmacists 
with regards to isolation requirements.
3. Calculate potential cost-savings based on 
intervention data.
Conclusion
 Pharmacist interventions for negative PCR 
showed a 71% (27/38) success rate in 
discontinuation of oseltamivir within 48 hours. 
 Successful antibiotic discontinuation for patients 
with a positive PCR result and normal 
procalcitonin was 63% (12/19). 
 Pharmacy identified 14.9% (11/74) of patients 
who required initiation of droplet isolation, and 
20.3% (15/74) who did not need it. 
 Overall, we estimated a total cost-saving of 
$4,057.83 during the study period as a result of 
pharmacist-driven ASP interventions. 
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